INS and metabolic dysfunction-associated steatotic liver disease: In particular, mTOR has been found to regulate lipid metabolism via SREBPs, insulin resistance, oxidative stress, intestinal microbiota, autophagy, inflammation, genetic polymorphisms, and epigenetics in NAFLD [26].